Cargando…

Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report

Here, we report a case of a patient with symptoms of Cushing syndrome, who is diagnosed with primary generalized glucocorticoid hypersensitivity in the end. The patient’s relevant laboratory tests and imaging examinations are described. Mifepristone, a glucocorticoid receptor antagonist, was prescri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yunfeng, Han, Minmin, Yang, Jing, Xu, Qishan, Xu, Linxi, Ren, Yi, Xiang, Chenyu, Liu, Zi’ang, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568610/ https://www.ncbi.nlm.nih.gov/pubmed/33116774 http://dx.doi.org/10.2147/IJGM.S273969

Ejemplares similares

Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone
por: Zhao, Xiu, et al.
Publicado: (2022)

Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update
por: Nicolaides, Nicolas C., et al.
Publicado: (2021)

To Assess Liraglutide’s Therapeutic Effect in Patients with Type 2 Diabetes Mellitus Using Flash Glucose Monitoring System
por: Yin, Jianhong, et al.
Publicado: (2021)

Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015)

Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression
por: Block, Thaddeus, et al.
Publicado: (2017)

Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men
por: Nguyen, Dat, et al.
Publicado: (2017)

Protective effects of glucocorticoid receptor antagonist Mifepristone on fear memory extinction impairment in a rat model of PTSD
por: Liu, Y.-P., et al.
Publicado: (2022)

Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer
por: Baker, Gabrielle M, et al.
Publicado: (2015)

Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription
por: Ma, Peng, et al.
Publicado: (2021)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

A patient with glucocorticoid hypersensitivity syndrome
por: Wu, Chenwei, et al.
Publicado: (2022)

Global clinical response in Cushing’s syndrome patients treated with mifepristone
por: Katznelson, Laurence, et al.
Publicado: (2014)

Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone
por: Michailidou, Zoi, et al.
Publicado: (2007)

Postreactivation mifepristone impairs generalization of strongly conditioned contextual fear memories
por: Flavell, Charlotte R., et al.
Publicado: (2020)

Mifepristone Increases the Cytotoxicity of Uterine Natural Killer Cells by Acting as a Glucocorticoid Antagonist via ERK Activation
por: Chen, Yuezhou, et al.
Publicado: (2012)

A Single-Day Treatment with Mifepristone Is Sufficient to Normalize Chronic Glucocorticoid Induced Suppression of Hippocampal Cell Proliferation
por: Hu, Pu, et al.
Publicado: (2012)

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
por: Yuen, Kevin C. J., et al.
Publicado: (2017)

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations
por: Brown, David R., et al.
Publicado: (2020)

Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats
por: Khom, Sophia, et al.
Publicado: (2022)

Flash glucose monitoring system was applied to cortisol treatment for a patient with congenital adrenal hyperplasia and 17α-hydroxylase deficiency
por: Xiang, Chenyu, et al.
Publicado: (2020)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

Mifepristone Treatment in Pregnant Murine Model Induced Mammary Gland Dysplasia and Postpartum Hypogalactia
por: Zhu, Hongmei, et al.
Publicado: (2020)

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
por: Cohan, Pejman, et al.
Publicado: (2019)

Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis
por: Xue, Hui-Ling, et al.
Publicado: (2016)

Q&A: Primary generalized glucocorticoid resistance
por: Chrousos, George
Publicado: (2011)

Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats
por: Vozella, Valentina, et al.
Publicado: (2021)

Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017)

Resetting the Stress System with a Mifepristone Challenge
por: Dalm, Sergiu, et al.
Publicado: (2018)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Clinical Utility of Mifepristone: Apprising the Expanding Horizons
por: Karena, Zalak V, et al.
Publicado: (2022)

THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)

Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
por: Esteve, Josep Lluis Carbonell, et al.
Publicado: (2013)

Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
por: Zhang, Huijuan, et al.
Publicado: (2016)

X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor–Progesterone–Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface
por: Colucci, Jennifer K., et al.
Publicado: (2013)

A Pilot Study of Mifepristone in Combat-Related PTSD
por: Golier, Julia A., et al.
Publicado: (2012)

Successful conservative management with methotrexate and mifepristone of cervical pregnancy
por: Shrestha, Eliza, et al.
Publicado: (2011)

Mifepristone improves chemo-radiation response in glioblastoma xenografts
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4e5ci73huc4dudspjdd3vl89et